Sudden cardiac arrest in patients following surgery for CHD

Ronald J Kanter1

  • 1Division of Cardiology,Nicklaus Children's Hospital,Miami,Florida,United States of America.

Cardiology in the Young
|January 14, 2017
PubMed

Insights

Sudden cardiac arrest after congenital heart defect (CHD) surgery is linked to defect complexity and residual issues. Implantable cardioverter-defibrillators offer effective prevention for many CHD patients.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Cardiac Surgery

Background:

  • Sudden cardiac arrest (SCA) is a significant concern following surgery for congenital heart defects (CHD).
  • Approximately 19% of deaths in CHD patients are sudden, with risk factors often poorly understood.
  • Tetralogy of Fallot is an exception, with better-understood risks due to its prevalence and historical outcomes.

Purpose of the Study:

  • To investigate the prevalence and risk factors for sudden cardiac arrest after congenital heart defect surgery.
  • To explore the specific contributing factors to risk in Tetralogy of Fallot.
  • To evaluate the role of electrophysiologic testing and implantable cardioverter-defibrillators in CHD patient management.

Main Methods:

  • Review of prevalence data for SCA post-CHD surgery.
  • Analysis of risk factors associated with various congenital heart defects.
  • Evaluation of historical, hemodynamic, and electrical features in Tetralogy of Fallot.
  • Assessment of electrophysiologic testing utility.
  • Review of implantable cardioverter-defibrillator efficacy in secondary and primary prevention.

Main Results:

  • SCA prevalence is primarily associated with congenital defect complexity and residual defects, particularly ventricular dysfunction.
  • Tetralogy of Fallot presents unique historical, hemodynamic, and electrical risk factors.
  • Electrophysiologic testing may aid in risk assessment for Tetralogy of Fallot.
  • Implantable cardioverter-defibrillators are highly effective for secondary SCA prevention in most CHD cases.

Conclusions:

  • Congenital heart defect complexity and residual issues are key drivers of SCA post-surgery.
  • Understanding specific risk factors for diverse CHD types remains crucial.
  • Implantable cardioverter-defibrillators are vital for secondary SCA prevention, with potential for enhanced primary prevention in the future.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
405
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
997
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
446
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593